Skip to content

Assessment of Pharmacokinetic Efficacy of Continuous Infusion of Meropenem in Septic Patients with Increased Renal Function

Assessment of Pharmacokinetic Efficacy of Continuous Infusion of Meropenem in Septic Patients with Increased Renal Function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1031240434
Enrollment
10
Registered
2024-10-25
Start date
2024-10-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis Sepsis

Interventions

To compare the achievement of PK/PD targets (50%T>MIC or 100%T>MIC) for the two dosing regimens in patients receiving intermittent bolus and continuous infusion meropenem for sepsis.

Sponsors

Ohbayashi Masayuki
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with sepsis or septic shock diagnosed by the Department of Emergency Medicine or the Department of Intensive Care at Showa University Hospital and scheduled to be administered or on meropenem at the time of admission 2) Patients with eGFR more than 85 mL/min 3) Patients who are 18 years of age or older at the time consent is obtained (4) Patients who have obtained written consent to participate in this study from the individual or surrogate

Exclusion criteria

Exclusion criteria: 1) Patients receiving renal replacement therapy 2) Patients with massive bleeding 3) Pregnant women 4) Patients who are judged to be ineligible as subjects by the primary doctor 5) Patients receiving valproate natrium, a contraindication to study drug administration 6) Patients with a history of hypersensitivity to any component of the study drug

Design outcomes

Primary

MeasureTime frame
The achievement of PK/PD targets (50%T>MIC or 100%T>MIC)

Contacts

Public ContactMasayuki Ohbayashi

Showa University School of Pharmacy

ohbayashi@pharm.showa-u.ac.jp+81-3-3784-8221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026